More research needed for treatment of primary progressive Multiple Sclerosis

Left, Anneke van der Walt; right, Helmut Butzkueven
at the annual "Kiss Goodbye to MS" awareness event

The MSBase Foundation is the largest international online registry in the world for neurologists studying multiple sclerosis and other neuro-immunological diseases. Central Clinical School's Professor Helmut Butzkueven is managing director of MSBase, and he and Associate Professor Anneke van der Walt, the Head of MS services at Alfred Health, recently co-authored a publication on a cohort study involving 1284 patients with primary progressive Multiple Sclerosis (PPMS) from MSBase's large, international, observational database.

They found that therapies, effective for other forms of MS, have no substantial effect on short- to medium-term disability outcomes in PPMS.